Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NE
2551
DELISTED
Noble Corporation
NE
| $4.06M | ﹤0.01% |
3,329,886
+101,530
| +3% | +$122K |
|
2552
Hooker Furnishings Corp
HOFT
$159M
| $4.05M | ﹤0.01% |
157,665
+6,063
| +4% | +$143K |
|
|
SDC
2553
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $4.04M | ﹤0.01% |
+462,552
| New | +$4.63M |
|
2554
Business First Bancshares
BFST
$1.05B
| $4.03M | ﹤0.01% |
161,527
+5,636
| +4% | +$138K |
|
|
MFSF
2555
DELISTED
MutualFirst Financial Inc
MFSF
| $4.01M | ﹤0.01% |
101,118
+29,839
| +42% | +$1.1M |
|
2556
Aprea Therapeutics
APRE
$8.42M
| $4.01M | ﹤0.01% |
+4,367
| New | +$2.4M |
|
|
KIN
2557
DELISTED
Kindred Biosciences, Inc.
KIN
| $4M | ﹤0.01% |
472,047
+15,379
| +3% | +$120K |
|
2558
Arcus Biosciences
RCUS
$3.67B
| $3.99M | ﹤0.01% |
394,994
+9,907
| +3% | +$83.3K |
|
2559
Costamare
CMRE
$1.74B
| $3.98M | ﹤0.01% |
417,567
+134,890
| +48% | +$1.08M |
|
2560
RPC Inc
RES
$1.39B
| $3.97M | ﹤0.01% |
758,250
+27,102
| +4% | +$122K |
|
2561
Regional Management Corp
RM
$300M
| $3.97M | ﹤0.01% |
132,223
+9,466
| +8% | +$287K |
|
2562
Limoneira
LMNR
$250M
| $3.94M | ﹤0.01% |
204,646
+4,392
| +2% | +$83.9K |
|
2563
Precision BioSciences
DTIL
$202M
| $3.93M | ﹤0.01% |
9,442
+4,741
| +101% | +$1.49M |
|
2564
Paysign
PAYS
$736M
| $3.93M | ﹤0.01% |
387,638
-4,663
| -1% | -$49K |
|
2565
Greenlight Captial
GLRE
$511M
| $3.93M | ﹤0.01% |
388,777
+15,832
| +4% | +$164K |
|
2566
HUTCHMED
HCM
$2.12B
| $3.93M | ﹤0.01% |
157,806
+5,294
| +3% | +$116K |
|
2567
Dianthus Therapeutics
DNTH
$6.12B
| $3.92M | ﹤0.01% |
16,165
+946
| +6% | +$177K |
|
|
GNTY
2568
DELISTED
Guaranty Bancshares
GNTY
| $3.92M | ﹤0.01% |
131,088
-3,497
| -3% | -$102K |
|
2569
Bridgewater Bancshares
BWB
$621M
| $3.9M | ﹤0.01% |
283,398
+8,461
| +3% | +$107K |
|
2570
Farmers & Merchants Bancorp
FMAO
$487M
| $3.9M | ﹤0.01% |
129,356
+2,123
| +2% | +$56.2K |
|
2571
Seneca Foods Class A
SENEA
$1.31B
| $3.88M | ﹤0.01% |
95,136
+11,708
| +14% | +$422K |
|
2572
VEON
VEON
$3.93B
| $3.87M | ﹤0.01% |
61,217
-23,658
| -28% | -$1.45M |
|
2573
Green Brick Partners
GRBK
$3.04B
| $3.87M | ﹤0.01% |
336,830
+17,317
| +5% | +$189K |
|
2574
PagSeguro Digital
PAGS
$2.43B
| $3.86M | ﹤0.01% |
112,919
+8,280
| +8% | +$298K |
|
|
CALA
2575
DELISTED
Calithera Biosciences, Inc
CALA
| $3.81M | ﹤0.01% |
33,368
+4,903
| +17% | +$369K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.